(Adnkronos) – Maurizio Rossini, full professor of rheumatology at the University of Verona and director of the rheumatology operating unit of the integrated university hospital of Verona, present at the press conference announcing the reimbursement of romosozumab, the new drug for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture, developed by UCB in collaboration with Amgen, illustrates the mechanism of action of the new drug.
#Fragility #fractures #Rossini #Romosozumab #leads #improvements #months
Women's Health Day, the 22nd free Lilt screening in the heart of Rome
Free screening and cancer prevention visits in the heart of Rome: this is how the Lilt Italian League against cancer...